data protection

Secure the data and access, not the personal device. Virtual desktops, browser controls and app protection, the controls every approach needs, and when to issue company devices anyway.

AI agents should get less default access than a new developer. OWASP Excessive Agency, the controls to enforce outside the prompt, and an access review for agents already running.

Stuck with a global payroll vendor that controls your records? What your contract, GDPR Article 28 and the EU Data Act give you, a step-by-step data request, and how to avoid lock-in next time.

A DMARC record at p=none reports on spoofing but does not stop it. How to find every sender, fix alignment and move to reject, plus what changed with RFC 9989.

Most Shopify VA horror stories are permissions failures, not people failures. A least-privilege staff permission set from Shopify’s own docs, the three highest-consequence mistakes and their controls, and onboarding and offboarding checklists built for a live store.

Is outsourcing to India safe in 2026? The real risks — data security, IP ownership and compliance — and the contract terms, certifications and controls that neutralise each, with AB7’s GDPR/HIPAA-aligned delivery from $1,500/month.

A practical playbook for protecting confidential and regulated data when outsourcing to India in 2026: NDAs, data-processing agreements, least-privilege access, ISO 27001 and SOC 2 controls, and HIPAA/GDPR alignment.

The 7 real risks of outsourcing to India — IP leakage, time-zone drift, quality variance, data compliance, lock-in, attrition, spec ambiguity — and the exact clause, tool, or metric that neutralizes each.

HIPAA penalties reach $2.13M per violation — but building a fully compliant remote healthcare team is being done by thousands of US practices right now. This step-by-step guide covers everything: BAAs, technical safeguards, access controls, monitoring, and scaling your team the right way.

FDA enforcement is at an all-time high and compliance talent is scarce. Discover why leading pharma companies are building outsourced documentation teams in India for regulatory submissions, pharmacovigilance, quality documentation, and clinical trials — at 65-75% lower cost.